International

FDA Adds New Warning To J&J Covid-19 Vaccine

US regulators on Monday added a new warning to Johnson & Johnson’s (J&J) COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction but said it’s not entirely clear the shot caused the problem. The Food and Drug Administration announced the new warning, flagging reports of Guillain-Barre syndrome, an immune system disorder that can causes muscle weakness and occasionally paralysis. Health officials described the side effect as a “small possible risk” for those getting the shot.\ The action comes after the FDA and the Centers for Disease Control and Prevention reviewed reports of about 100 people developing the syndrome after receiving the one-dose vaccine. Almost all of them required hospitalization and one person died, the FDA said Guillain-Barre syndrome occurs when the body’s immune system mistakenly attacks some of its nerve cells, causing muscle weakness and sometimes paralysis that typically is temporary.…

International

UNICEF To Supply 220 Million Doses Of The Johnson & Johnson To African Union

The United Nations Children’s Emergency Fund (Unicef) has announced the signing of an agreement with Janssen Pharmaceutica NV to supply 220 million doses of the Johnson & Johnson (J&J) single-dose vaccine against Covid-19 for all 55 member states of the African Union (AU) by the end of 2022. Some 35 million doses are to be delivered by the end of 2021, Xinhua news agency quoted Unicef as saying in a statement on Thursday. The agreement between Unicef and Janssen will help implement the Advance Purchase Commitment signed between the African Vaccine Acquisition Trust (AVAT) and Janssen in March 2021. That agreement secured an option to order another 180 million doses, bringing the maximum access up to a total of 400 million doses by the end of 2022, said the UN agency. The AU established AVAT in November 2020 to deliver Covid-19 vaccines to the…